T细胞促进角质形成细胞与真皮成纤维细胞中皮肤炎症性疾病的独特转录程序
研究探讨功能多样的循环及皮肤驻留CD4+CLA+ T细胞群体如何促使人角质形成细胞和成纤维细胞产生与炎症或健康组织相关的不同转录结果。研究发现Th17细胞诱导的角质形成细胞基因在银屑病患者皮肤中富集并可被抗IL-17治疗正常化;CD103+皮肤驻留T细胞诱导的转录模块在健康对照中富集,在银屑病和硬皮病中减弱。利用免疫依赖性转录特征分析临床数据可定义区分炎症与健康皮肤的T细胞亚群和基因,并探究患者对生物制剂治疗的异质性反应。
要点
- Th17诱导的角质形成细胞基因在银屑病皮损中富集,抗IL-17治疗可使其正常化
- CD103+皮肤驻留T细胞诱导的转录模块在健康对照中富集,在银屑病和硬皮病中减弱
- 免疫依赖性转录特征可用于区分炎症与健康皮肤并探究生物制剂反应的异质性
核心结论
- 功能多样的循环及皮肤驻留CD4+CLA+ T细胞群体促使人角质形成细胞和成纤维细胞产生与炎症或健康组织相关的不同转录结果。
研究设计与样本
- 研究分析了功能多样的循环及皮肤驻留CD4+CLA+ T细胞群体对人角质形成细胞和成纤维细胞转录结果的影响。
主要发现
- Th17细胞诱导的角质形成细胞基因在银屑病患者皮肤中富集,并可通过抗IL-17治疗正常化。
- CD103+皮肤驻留T细胞诱导的转录模块在健康对照中富集,在银屑病和硬皮病中减弱。
- CD103+ T细胞频率在疾病期间发生改变。
- 利用免疫依赖性转录特征分析临床数据可定义区分炎症与健康皮肤的T细胞亚群和基因,并探究患者对生物制剂治疗的异质性反应。
临床怎么用
- 免疫依赖性转录特征可用于区分炎症与健康皮肤,并有助于探究患者对生物制剂治疗的异质性反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T cells and structural cells coordinate appropriate inflammatory responses and restoration of barrier integrity following insult. Dysfunctional T cells precipitate skin pathology occurring alongside altered structural cell frequencies and transcriptional states, but to what extent different T cells promote disease-associated changes remains unclear. We show that functionally diverse circulating and skin-resident CD4+CLA+ T-cell populations promote distinct transcriptional outcomes in human keratinocytes and fibroblasts associated with inflamed or healthy tissue. We identify T helper 17 cell-induced genes in keratinocytes that are enriched in psoriasis patient skin and normalized by anti-IL-17 therapy. We also describe a CD103+ skin-resident T-cell-induced transcriptional module enriched in healthy controls that is diminished during psoriasis and scleroderma and show that CD103+ T-cell frequencies are altered during disease. Interrogating clinical data using immune-dependent transcriptional signatures defines the T-cell subsets and genes distinguishing inflamed from healthy skin and allows investigation of heterogeneous patient responses to biologic therapy.
引用
- DeBerg HA, Fahning ML, Varkhande SR, et al. T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts. J Invest Dermatol. 2025. PMID: 40216155. doi:10.1016/j.jid.2025.03.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。